138 results
Page 2 of 7
8-K
EX-99.1
z7pds87t5xrt84g1v684
14 Aug 23
Gamida Cell Reports Second Quarter and First Half 2023 Financial Results and Provides Company Update
7:30am
8-K
EX-99.1
osdl87ly1m3884
22 May 23
Gamida Cell Appoints Terry Coelho as CFO
8:55am
8-K
EX-3.1
60xrh0x
19 May 23
Amendments to Articles of Incorporation or Bylaws
4:01pm
8-K
EX-99.1
3qp4rkni7lrrnv 5bb
15 May 23
Gamida Cell Reports First Quarter 2023 Financial Results and Provides Company Update
12:00am
8-K
EX-1.1
vg593kgl6jaa56
21 Apr 23
Gamida Cell Announces Launch of Public Offering of Securities
7:19am
8-K
EX-99.1
87zeetlfns1grgq24
21 Apr 23
Gamida Cell Announces Launch of Public Offering of Securities
7:19am
8-K
EX-99.2
ssk s3aobt04sfe
21 Apr 23
Gamida Cell Announces Launch of Public Offering of Securities
7:19am
8-K
EX-99.1
i3vfm6q 6uklvuxhvrw5
17 Apr 23
Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval
5:29pm
8-K
EX-99.1
v6huv834 f2evhdutx
12 Dec 22
Gamida Cell Announces Closing of $25 Million Financing with Highbridge
7:15am
8-K
EX-10.1
6xxhpmzybuzv4o8n
12 Dec 22
Gamida Cell Announces Closing of $25 Million Financing with Highbridge
7:15am
8-K
EX-99.1
5rmxceek1s
21 Nov 22
Gamida Cell Provides Regulatory Update on Omidubicel
5:20pm
8-K
EX-99.1
kjcoh2n68s8a0yst1ffl
14 Nov 22
Gamida Cell Reports Third Quarter 2022 Financial Results
7:15am
8-K
EX-99.1
j5z0suuc4jrjb4
30 Sep 22
Gamida Cell Announces Pricing of Approximately $20 Million Public Offering of Ordinary Shares
4:02pm
8-K
EX-1.1
xdxgey5
30 Sep 22
Gamida Cell Announces Pricing of Approximately $20 Million Public Offering of Ordinary Shares
4:02pm
8-K
EX-99.1
upo4i0ke3cwbdob2s0
27 Sep 22
Gamida Cell Announces Launch of Public Offering of Ordinary Shares
5:03pm
8-K
EX-99.1
kla6p
19 Sep 22
Departure of Directors or Certain Officers
7:06am